0001567619-18-001171.txt : 20180815
0001567619-18-001171.hdr.sgml : 20180815
20180815151407
ACCESSION NUMBER: 0001567619-18-001171
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180813
FILED AS OF DATE: 20180815
DATE AS OF CHANGE: 20180815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofia Michael J.
CENTRAL INDEX KEY: 0001635324
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 181020825
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORP.
STREET 2: SUITE 100, 8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2018-08-13
2018-08-14
0
0001447028
Arbutus Biopharma Corp
ABUS
0001635324
Sofia Michael J.
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Scientific Officer
Common Shares
1503403
D
Common Shares
2018-08-13
4
S
0
4250
9.5143
D
167162
I
Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.5073 to $9.5525, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
/s/ David C. Hastings, as attorney-in-fact for Michael J. Sofia
2018-08-15